GBA1 and Parkinson disease: How GBA mutations predispose to PD and LBD remains unclear.2,3 In GD it is hypothesized that biallelic GBA mutations cause lysosomal dysfunction, impaired alpha-synuclein degradation, and impaired LB formation.27 Enzyme replacement therapy cannot penetrate the blood brain barrier, so this hypothesis remains valid in treated GD patients.